Skip to Main Content
Table 1—

Comparison of original model and patient preferences for glucose control treatments and microvascular complications

SourcesUtilities for complications
Utilities for treatments
BlindnessChronic renal failure with hemodialysisAmputationConventional glucose controlIntensive glucose control
Oral medicationsInsulin
Original model utilities (refs. 17–19) 0.69 0.61 0.80 
Patient utilities 0.39 (0.36–0.42) 0.36 (0.34–0.39) 0.45 (0.42–0.48) 0.76 (0.74–0.78) 0.77 (0.75–0.80) 0.64 (0.61–0.67) 
SourcesUtilities for complications
Utilities for treatments
BlindnessChronic renal failure with hemodialysisAmputationConventional glucose controlIntensive glucose control
Oral medicationsInsulin
Original model utilities (refs. 17–19) 0.69 0.61 0.80 
Patient utilities 0.39 (0.36–0.42) 0.36 (0.34–0.39) 0.45 (0.42–0.48) 0.76 (0.74–0.78) 0.77 (0.75–0.80) 0.64 (0.61–0.67) 

Data are means (95% CI), unless otherwise indicated.

Close Modal

or Create an Account

Close Modal
Close Modal